Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Clinical Characteristics and Risk Factors for Adverse Outcomes of Influenza Infections in Hematopoietic Stem Cell Transplant Recipients

Brian J. Chernak, MD, Emily Coskun, MD, Nina Orfali, MB,PhD, Yuqing Qiu, MS, Rosemary Soave, MD, Tsiporah B. Shore, MD, Koen van Besien, MD PhD, Mirella Salvatore, MD

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-141254

Published: 2020

Journal Articles

A Phase I Study of Selinexor and R-ICE in Patients with Relapsed/Refractory Aggressive B-Cell Lymphomas

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-134699

Published: 2020

Journal Articles

Timing of Daratumumab Administered Pre-Mobilization in Multiple Myeloma Impacts Pre-Harvest Peripheral Blood CD34+ Cell Counts and Plerixafor Use

Danny Luan, MPH, Paul J Christos, Dr.P.H., M.S., Michael Ancharski, MLS(ASCP), Danielle Guarneri, BS, CCRP, Roger Pearse, MD PhD, Adriana C Rossi, MD MSc, Tsiporah B. Shore, MD, Sebastian Mayer, MD, Adrienne A. Phillips, MD MPH, Jingmei Hsu, MD, Ljiljana V. Vasovic, MD, Yen-Michael S. Hsu, MD PhD, Koen van Besien, MD PhD, Ruben Niesvizky, MD, Cara A. Rosenbaum, MD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-140811

Published: 2020

Journal Articles

Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration

Nina Orfali, MB,PhD, Alexandra Gomez-Arteaga, MD, Danielle Guarneri, BS, CCRP, Jingmei Hsu, MD, Adrienne A. Phillips, MD MPH, Usama Gergis, MD MBA, Tsiporah B. Shore, MD, Sebastian A. Mayer, MD, Koen Van Besien, MD PhD

Blood (2019) 134 (Supplement_1): 2000.

https://doi.org/10.1182/blood-2019-129452

Published: 2019

Journal Articles

Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34 + progenitor Cells

Alexandra Gomez-Arteaga, MD, Nina Orfali, MB,PhD, Danielle Guarneri, BS, CCRP, Usama Gergis, MD MBA, Sebastian A. Mayer, MD, Jingmei Hsu, MD, Adrienne A. Phillips, MD MPH, Tsiporah B. Shore, MD, Koen Van Besien, MD PhD

Blood (2019) 134 (Supplement_1): 2040.

https://doi.org/10.1182/blood-2019-129584

Published: 2019

Journal Articles

Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion

Jingmei Hsu, MD, Usama Gergis, MD MBA, Tsiporah B. Shore, MD, Sebastian Mayer, MD, Adrienne A. Phillips, MD MPH, Danielle Guarneri, BS, CCRP, Maria Baldo, PA, Ljiljana V. Vasovic, MD, Yen-Michael S. Hsu, MD PhD, Robert Andrew Desimone, MD, Melissa M. Cushing, MD, Koen Van Besien, MD PhD

Blood (2019) 134 (Supplement_1): 1169.

https://doi.org/10.1182/blood-2019-131306

Published: 2019

Journal Articles

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

Tsiporah B. Shore, MD, Jessy B. Ryan, ANP, Michael B. Samuel, MD

Blood (2019) 134 (Supplement_1): 5687.

https://doi.org/10.1182/blood-2019-122715

Published: 2019

Journal Articles

Comparison of Early Versus Delayed Filgrastim (G-CSF) Administration Following Autologous Stem Cell Transplantation in Patients with Multiple Myeloma - Real-World Data from a Single-Center Institution

Blood (2019) 134 (Supplement_1): 5644.

https://doi.org/10.1182/blood-2019-130914

Published: 2019

Journal Articles

Correlations between Pre-Transplant Treatment and Bone Marrow Response with Post-Transplant Outcomes in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation

Pinkal Desai, MD MPH, Alfadel Alshaibani, MD, Xian Wu, MPH, Sangmin Lee, MD, Jingmei Hsu, MD, Ellen K. Ritchie, MD, Michael Samuel, MD, Sebastian A. Mayer, MD, Adrienne A. Phillips, MD MPH, Usama Gergis, MD M.B.A, Tsiporah B. Shore, MD, Koen Van Besien, MD PhD, Gail J. Roboz, MD

Blood (2018) 132 (Supplement 1): 4391.

https://doi.org/10.1182/blood-2018-99-118366

Published: 2018

Journal Articles

Cord Blood Transplants Supported By Unrelated Donor CD34 Progenitor Cells

Alexandra Gomez-Arteaga, MD, Danielle Guarneri, CCRP, Usama Gergis, MD M.B.A, Jingmei Hsu, MD, Sebastian A. Mayer, MD, Adrienne A. Phillips, MD MPH, Tsiporah B. Shore, MD, Koen Van Besien, MD PhD

Blood (2018) 132 (Supplement 1): 4646.

https://doi.org/10.1182/blood-2018-99-115502

Published: 2018

Journal Articles

Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?

Sangmin Lee, MD, Jingmei Hsu, MD, Yassine Tahri, MD, Zhengming Chen, PhD MPH, MS, Tsiporah B. Shore, MD, Ellen K. Ritchie, MD, Usama Gergis, MD M.B.A, Pinkal Desai, MD MPH, Sebastian A. Mayer, MD, Michael Samuel, MD, Adrienne A. Phillips, MD MPH, Melissa M. Cushing, MD, Gail J. Roboz, MD, Koen Van Besien, MD PhD

Blood (2018) 132 (Supplement 1): 2172.

https://doi.org/10.1182/blood-2018-99-119946

Published: 2018

Journal Articles

CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV + /AML Patient: A Case Report from the Impaact P1107 Observational Study

Jingmei Hsu, MD, Marshall Glesby, MDPhD, Tsiporah B. Shore, MD, Catherine Small, MD, Usama Gergis, MD M.B.A, Sebastian A. Mayer, MD, Adrienne A. Phillips, MD MPH, Lawrence D. Petz, MD, Renee Browning, RN, M.S.N, CCRP, Meredith Warshaw, Deborah Persaud, MD, Bryson Yvonne, MD, Koen Van Besien, MD PhD

Blood (2018) 132 (Supplement 1): 2184.

https://doi.org/10.1182/blood-2018-99-117734

Published: 2018

Journal Articles

Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma

Madhav Seshadri, MD, Zhengming Chen, PhD MPH, MS, Peter Martin, FRCPC, MD MS, John P. Leonard, MD, Tsiporah B. Shore, MD, Adrienne A. Phillips, MD MPH, Usama Gergis, MD M.B.A, Sarah C. Rutherford, John N. Allan, MD, Richard R. Furman, MD, Kristy Richards, MD PhD, Jingmei Hsu, MD, Sebastian A. Mayer, MD, Arcania Garcia, Channy Kong, Giorgio Inghirami, MD, Koen Van Besien, MD PhD, Jia Ruan, MD PhD

Blood (2018) 132 (Supplement 1): 1640.

https://doi.org/10.1182/blood-2018-99-111476

Published: 2018

Journal Articles

Studies of White Cell, Platelet, and Coagulation Activation with Plerixafor Administration in Patients with Sickle Cell Disease

Petra Pham, Mihaela Barbu-Stevanovic, June Greenberg, RN, Danielle Guarneri, Beau Mitchell, MD, Caterina Minniti, MD, Mohandas Narla, DSc, Karina Yazdanbakhsh, PhD, Tsiporah B. Shore, MD, Farid Boulad, MD, Michel Sadelain, MD PhD, Patricia Shi, MD

Blood (2017) 130 (Supplement 1): 963.

https://doi.org/10.1182/blood.V130.Suppl_1.963.963

Published: 2017

Journal Articles

Adoptive Immunotherapy with Cord Blood (CB) Grafts Targeting Shared Inherited Paternal Antigens (IPA) and/or Non-Inherited Maternal Antigens (NIMA) during Induction Treatment for High Risk Myeloid Malignancies: Safety and Preliminary Results

Usama Gergis, MD, Koen Van Besien, MD PhD, Emeline Masson Frenet, PhD, Tsiporah B. Shore, MD, Sebastian A. Mayer, MD, Adrienne A. Phillips, MD MPH, Jingmei Hsu, MD PhD, Gail J. Roboz, MD, Ellen K Ritchie, MD, Joseph Scandura, MDPhD, Sangmin Lee, MD, Pinkal Desai, MDMPH, Michael Samuel, MD, Jeffrey Ball, MD, Maria S. Albano, PhD, Rodica Ciubotariu, MD PhD, Ludy Dobrila, PhD, Cynthia Romeo, PhD, Andromachi Scaradavou, MD

Blood (2017) 130 (Supplement 1): 2627.

https://doi.org/10.1182/blood.V130.Suppl_1.2627.2627

Published: 2017

Journal Articles

A Phase II Study of a Novel Conditioning Regimen of Bendamustine and Melphalan Followed By Autologous Stem Cell Transplant for Patients with Multiple Myeloma

Alexandra Gomez-Arteaga, MD, Tomer M Mark, MDMSc, Danielle Guarneri, Paul J Christos, Dr.P.H., M.S., Usama Gergis, MD, June Greenberg, RN, Jingmei Hsu, MD PhD, Sebastian A. Mayer, MD, Ruben Niesvizky, MD, Roger Pearse, MD PhD, Adrienne A. Phillips, MD MPH, Adriana C. Rossi, MDMSc, Morton Coleman, MD, Koen Van Besien, MD PhD, Tsiporah B. Shore, MD

Blood (2017) 130 (Supplement 1): 4546.

https://doi.org/10.1182/blood.V130.Suppl_1.4546.4546

Published: 2017

Journal Articles

Novel Risk Factors for Epstein-Barr Virus (EBV) Reactivation and Post-Transplant Lymphoproliferative Disorder (PTLD) after Allogeneic Hematopoietic Stem Cell Transplant

Lizamarie Bachier Rodriguez, MD, Tsiporah B. Shore, MD, Usama Gergis, MD, Jingmei Hsu, MD PhD, Adrienne A. Phillips, MD MPH, Sebastian A. Mayer, MD, Hanna Rennert, PhD, Koen Van Besien, MD PhD

Blood (2017) 130 (Supplement 1): 1949.

https://doi.org/10.1182/blood.V130.Suppl_1.1949.1949

Published: 2017

Journal Articles

Kidney Dysfunction Post-Allogeneic Transplant: High Incidence of TMA and Kidney GvHD

Hannah K. Choe, MD, Vesh Srivatana, MD, Usama Gergis, MD, Tsiporah B. Shore, MD, Sebastian A. Mayer, MD, Jingmei Hsu, MD PhD, Adrienne A. Phillips, MD MPH, Surya V. Seshan, MD, Thangamani Muthukumar, MD, Koen Van Besien, MD PhD

Blood (2017) 130 (Supplement 1): 5500.

https://doi.org/10.1182/blood.V130.Suppl_1.5500.5500

Published: 2017

Journal Articles

Safety and Efficacy Trial of Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells (HPCs) for Globin Gene Transfer in Patients with Sickle Cell Disease

Farid Boulad, MD, Tsiporah B. Shore, MD, Koen Van Besien, MD PhD, Danielle Guarneri, June Greenberg, RN, Caterina Minniti, MD, Sylvie wiener Fedus, Fabiana Perna, MD, Xiuyan Wang, PhD, Isabelle Riviere, PhD, Michel Sadelain, MD PhD, Patricia Shi, MD

Blood (2017) 130 (Supplement 1): 3531.

https://doi.org/10.1182/blood.V130.Suppl_1.3531.3531

Published: 2017

Journal Articles

Fludarabine Melphalan Conditioning Followed By T-Replete Haplo Identical (Haplo) Transplantation or Haplo Cord (HC) Transplantation

Koen Van Besien, MD PhD, Andrew Artz, MD, Richard E Champlin, MD, Danielle Guarneri, Michael R. Bishop, MD, Julianne Chen, Tsiporah B. Shore, MD, Hongtao Liu, MD PhD, Gabriela Rondon, MD, Sebastian A. Mayer, MD, Stefan O. Ciurea

Blood (2017) 130 (Supplement 1): 3328.

https://doi.org/10.1182/blood.V130.Suppl_1.3328.3328

Published: 2017

NARROW

Clinical Characteristics and Risk Factors for Adverse Outcomes of Influenza Infections in Hematopoietic Stem Cell Transplant Recipients

A Phase I Study of Selinexor and R-ICE in Patients with Relapsed/Refractory Aggressive B-Cell Lymphomas

Timing of Daratumumab Administered Pre-Mobilization in Multiple Myeloma Impacts Pre-Harvest Peripheral Blood CD34+ Cell Counts and Plerixafor Use

Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration

Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34 + progenitor Cells

Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

Comparison of Early Versus Delayed Filgrastim (G-CSF) Administration Following Autologous Stem Cell Transplantation in Patients with Multiple Myeloma - Real-World Data from a Single-Center Institution

Correlations between Pre-Transplant Treatment and Bone Marrow Response with Post-Transplant Outcomes in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation

Cord Blood Transplants Supported By Unrelated Donor CD34 Progenitor Cells

Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?

CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV + /AML Patient: A Case Report from the Impaact P1107 Observational Study

Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma

Studies of White Cell, Platelet, and Coagulation Activation with Plerixafor Administration in Patients with Sickle Cell Disease

Adoptive Immunotherapy with Cord Blood (CB) Grafts Targeting Shared Inherited Paternal Antigens (IPA) and/or Non-Inherited Maternal Antigens (NIMA) during Induction Treatment for High Risk Myeloid Malignancies: Safety and Preliminary Results

A Phase II Study of a Novel Conditioning Regimen of Bendamustine and Melphalan Followed By Autologous Stem Cell Transplant for Patients with Multiple Myeloma

Novel Risk Factors for Epstein-Barr Virus (EBV) Reactivation and Post-Transplant Lymphoproliferative Disorder (PTLD) after Allogeneic Hematopoietic Stem Cell Transplant

Kidney Dysfunction Post-Allogeneic Transplant: High Incidence of TMA and Kidney GvHD

Safety and Efficacy Trial of Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells (HPCs) for Globin Gene Transfer in Patients with Sickle Cell Disease

Fludarabine Melphalan Conditioning Followed By T-Replete Haplo Identical (Haplo) Transplantation or Haplo Cord (HC) Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only